Urologix In-Office BPH Therapies to be Featured on In View Hosted by Larry King

Urologix In-Office BPH Therapies to be Featured on In View Hosted by Larry

The segment will follow a man suffering from BPH, and his wife through their
struggles with his enlarged prostate, how he found relief through an in-office
procedure, and the quality of life improvements they have experienced since he
had the procedure.

MINNEAPOLIS, Minn., April 2, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Urologix,
Inc. (OTCQB:ULGX) the leading provider of in-office procedures for the safe,
durable and effective treatment of BPH, today announced that it will be
featured on the televised series In View, hosted by Larry King. The In View
program will air on the Fox Business Network, Saturday April 5th, 2014 at
1:00pm, EDT and PDT. The segment will discuss Benign Prostatic Hyperplasia
(BPH) and educate BPH sufferers and their significant others on effective,
non-surgical, in-office treatment options as alternatives to BPH medications.
Highlights from the upcoming show will be available at

BPH, also known as enlarged prostate, affects the majority of men as they age
and can create irritating symptoms which significantly impact quality of life.
This disease continues to be predominantly treated with daily medications.
However, research has shown that drugs are not always effective and can
produce unpleasant side effects. The In View segment will highlight safe,
long-lasting and effective in-office BPH therapies which can be excellent
alternatives to chronic medication. Cooled ThermoTherapy™ and Prostiva® RF
Therapy, the market leading non-surgical options, have proven their results
through numerous clinical studies and are recommended treatment options from
the American Urology Association guidelines.

The show features Dr. J. Randolf Beahrs, a board certified urologist and
Director of Minimally Invasive Office Procedures at Metro Urology in St. Paul,
Minnesota and a BPH patient who underwent a Prostiva RF Therapy procedure. Dr.
Beahrs has extensive urologic experience and has treated numerous patients
using both Cooled ThermoTherapy and Prostiva RF Therapy.

"I was excited to participate in this feature on Benign Prostate Hyperplasia.
It will help educate patients about the disease and provide information on
treatment options that can be more effective than medications and avoid their
side effects." stated Dr. Beahrs. "We can now offer state-of-the-art
office-based solutions which result in excellent outcomes for our patients and
provide a great value for the patient, physician, and healthcare system. "

Visit http://www.beatbph.com to learn more about BPH and other common
prostatic conditions and to find a urologist near you.

About Urologix
Urologix, Inc., based in Minneapolis, develops, manufactures, markets and
distributes minimally invasive medical products for the treatment of
obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). Urologix's
Cooled ThermoTherapy produces targeted microwave energy combined with a unique
cooling mechanism to protect healthy tissue and enhance patient comfort. The
Prostiva RF Therapy System delivers radio frequency energy directly into the
prostate destroying prostate tissue, reducing constriction of the urethra, and
thereby relieving BPH symptoms. Both of these therapies provide safe,
effective and lasting relief of obstruction and symptoms due to BPH. Prostiva
is a registered trademark of Medtronic, Inc., used under license. All other
trademarks are the property of Urologix.

Federal USA law restricts these devices to sale by or on the order of a
physician. For more complete information about the benefits, risks and
contraindications associated with Cooled ThermoTherapy and Prostiva RF
Therapy, please refer to the product labeling which accompanies the device and
can be found at http://www.urologix.com.

If you would like more information on this topic, please contact Susan Overby
at 763-745-1540 or soverby(at)urologix(dot)com. To learn more about Urologix
and its products and services, visit http://www.urologix.com.

The Urologix logo is available at

Urologix Media Contact
Susan Overby

Urologix Investor Relations Contact
Brian Smrdel
(763) 475-7696

This article was originally distributed on PRWeb. For the original version
including any supplementary images or video, visit

CONTACT: Urologix, Inc.
         Susan Overby
         +1 (763) 745-1540
Press spacebar to pause and continue. Press esc to stop.